animated banner
Public Employers Students Media More   en français

 Nursing Standards 

 Last modified September 10, 2004 

Additions to the RN(EC) Drug List
September 2004

[français]

When circumstances are set out for a drug in Schedule 3, an RN(EC) shall only prescribe the drug in those circumstances. Until now, routes and/or purposes are the two circumstances identified for certain drugs. The August 2004 amendments to Schedule 3 also include the condition "for renewal only" when prescribing certain drugs.

Related resource:

An RN(EC) who prescribes a drug that is authorized "for renewal only" is accountable for all of the following:

  • Knowing that the drug has been prescribed for the client on an ongoing basis for a period of time;
  • Knowing that the client's ongoing response to the drug is predictable, typical, and well-established;
  • Determining that the client's condition has not destabilized or deteriorated and that the established drug regimen remains appropriate for the client;
  • Writing the prescription as previously prescribed by the physician without changes to dose, route, frequency;
  • Consulting with a physician to discuss any question or concern regarding continued use of the drug as originally prescribed.

1. Schedule 3 to Ontario Regulation 275/94 is amended by adding the following:

  • Acarbose - for renewal only
  • Alendronate sodium - for renewal only
  • Amantadine hydrochloride
  • Amlodipine besylate - for renewal only
  • Atenolol - for renewal only
  • Beclomethasone dipropionate (inhalation) - for renewal only
  • Budesonide - for renewal only
  • Cefprozil
  • Cefuroxime axetil (oral)
  • Celecoxib - for renewal only
  • Ciprofloxacin HC (otic)
  • Collagenase
  • Conjugated Estrogens
  • Conjugated Estrogens and medroxyprogesterone acetate
  • Cyanocobalamin (Vitamin B12)
  • Diltiazem - for renewal only
  • Enalapril maleate - for renewal only
  • Erythromycin ethylsuccinate/sulfisoxazole acetyl
  • Estradiol-17 beta (micronized)
  • Estradiol-17 beta (transdermal)
  • Estradiol-17 beta (Silastic ring)
  • Estropipate (piperazine estrone sulfate)
  • Estradiol-17 beta hemihydrate
  • Estradiol-17 beta norethindrone acetate
  • Estrone (cone or cream)
  • Etidronate disodium/ calcium carbonate - for renewal only
  • Fluconazole (oral) - for renewal only
  • Fluticasone propionate (inhalation) - for renewal only
  • Fluticasone propionate (nasal)
  • Formoterol fumarate dihydrate -for renewal only
  • Furosemide - for renewal only
  • Gentamicin sulphate (otic, ophthalmic and topical)
  • Gliclazide - for renewal only
  • Glyburide -for renewal only
  • Haloperidol - for chronic nausea in palliation
  • Hydrochlorothiazide - for renewal only
  • Hydrocortisone-17-valerate
  • Imiquimod
  • Ipatropium bromide - for renewal only
  • Ipatropium bromide/salbutamol sulfate - for renewal only
  • Ketoconazole (topical)
  • Levonorgestrel releasing intrauterine system
  • Levothyroxine sodium - for renewal only
  • Meloxicam - for renewal only
  • Metformin hydrochloride - for renewal only
  • Minocycline hydrochloride
  • Misoprostol
  • Mometasone furoate monohydrate
  • Nifedipine - for renewal only
  • Norethindrone acetate/ethinyl estradiol
  • Oseltamavir phosphate
  • Progesterone
  • Raloxifene HCL - for renewal only
  • Ramipril - for renewal only
  • Ranitidine HCL (oral)
  • Risedronate sodium hemi-pentahydrate - for renewal only
  • Rofecoxib - for renewal only
  • Salmeterol xinafoate -for renewal only
  • Salmeterol xinafoate/fluticasone propionate - for renewal only
  • Terbutaline sulfate -for renewal only
  • Tretinoin (topical)
  • Triamcinolone acetonide
  • Trichloracetic acid 50-80% , Bichloracetic acid 50-80%
  • Zanamivir

In addition, the following changes are made to drugs already on the RN(EC) list:

  • Lorazepam (injectable preparation and oral) - in an emergency
  • Medroxyprogesterone acetate (injectable preparation and oral)
  • Salbutamol (inhaler or nebulizer solution) - in an emergency or for renewal

[top]